Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig C Hofmeister

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
How to Integrate Elotuzumab and Daratumumab Into Therapy for Multiple MyelomaCraig C Hofmeister, Sagar Lonial
Current Hematology Reports|October 20, 2005
Mucosal protection by cytokinesCraig C Hofmeister, Patrick J Stiff
Expert Review of Molecular Diagnostics|August 8, 2014
The potential of miRNAs as biomarkers for multiple myelomaAlberto Rocci, Craig C Hofmeister, Flavia Pichiorri
Hematology (Amsterdam, Netherlands)|December 3, 2005
Evaluation of pulmonary infiltrates in patients after stem cell transplantationSteve Scaglione, Craig C Hofmeister, Patrick Stiff
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2008
The effect of statin use at the time of autologous transplant on response and survival in multiple myelomaMehdi Hamadani, Erinn Hade, Don M Benson, et al.
Lancet (London, England)|June 8, 2019
Registering a CD38 antibody upfront for multiple myelomaCraig C Hofmeister, Ajay Nooka, Jonathan L Kaufman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 16, 2007
Clinical utility of autopsy after hematopoietic stem cell transplantationCraig C Hofmeister, David E Marinier, Cheryl Czerlanis, et al.
American Journal of Hematology|February 20, 2010
TTP disease course is independent of myeloma treatment and responseCraig C Hofmeister, Ming Jin, Spero R Cataland, et al.
Medical Oncology (Northwood, London, England)|December 26, 2012
Phase I pilot study of oxaliplatin, infusional 5-FU, and cetuximab in recurrent or metastatic head and neck cancerJoseph I Clark, Joshua B Greene, Ann Lau Clark, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2004
Graft-versus-host disease of the skin: life and death on the epidermal edgeCraig C Hofmeister, Adam Quinn, Kenneth R Cooke, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
How to Integrate Elotuzumab and Daratumumab Into Therapy for Multiple MyelomaCraig C Hofmeister, Sagar Lonial
Current Hematology Reports|October 20, 2005
Mucosal protection by cytokinesCraig C Hofmeister, Patrick J Stiff
Expert Review of Molecular Diagnostics|August 8, 2014
The potential of miRNAs as biomarkers for multiple myelomaAlberto Rocci, Craig C Hofmeister, Flavia Pichiorri
Hematology (Amsterdam, Netherlands)|December 3, 2005
Evaluation of pulmonary infiltrates in patients after stem cell transplantationSteve Scaglione, Craig C Hofmeister, Patrick Stiff
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2008
The effect of statin use at the time of autologous transplant on response and survival in multiple myelomaMehdi Hamadani, Erinn Hade, Don M Benson, et al.
Lancet (London, England)|June 8, 2019
Registering a CD38 antibody upfront for multiple myelomaCraig C Hofmeister, Ajay Nooka, Jonathan L Kaufman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 16, 2007
Clinical utility of autopsy after hematopoietic stem cell transplantationCraig C Hofmeister, David E Marinier, Cheryl Czerlanis, et al.
American Journal of Hematology|February 20, 2010
TTP disease course is independent of myeloma treatment and responseCraig C Hofmeister, Ming Jin, Spero R Cataland, et al.
Medical Oncology (Northwood, London, England)|December 26, 2012
Phase I pilot study of oxaliplatin, infusional 5-FU, and cetuximab in recurrent or metastatic head and neck cancerJoseph I Clark, Joshua B Greene, Ann Lau Clark, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2004
Graft-versus-host disease of the skin: life and death on the epidermal edgeCraig C Hofmeister, Adam Quinn, Kenneth R Cooke, et al.
Pageof 13